Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 7

1.

Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate.

Lenart BA, Lorich DG, Lane JM.

N Engl J Med. 2008 Mar 20;358(12):1304-6. doi: 10.1056/NEJMc0707493. No abstract available.

2.

Alendronate-related femoral diaphysis fracture--what should be done to predict and prevent subsequent fracture of the contralateral side?

Edwards MH, McCrae FC, Young-Min SA.

Osteoporos Int. 2010 Apr;21(4):701-3. doi: 10.1007/s00198-009-0986-y. Epub 2009 Jun 27. Review.

PMID:
19562241
3.

Risk of atypical femoral fracture with long-term use of alendronate (bisphosphonates) : a systemic review of literature.

Agarwal S, Agarwal S, Gupta P, Agarwal PK, Agarwal G, Bansal A.

Acta Orthop Belg. 2010 Oct;76(5):567-71. Review.

PMID:
21138208
4.

Atypical fractures of the femur and bisphosphonate therapy: A systematic review of case/case series studies.

Giusti A, Hamdy NA, Papapoulos SE.

Bone. 2010 Aug;47(2):169-80. doi: 10.1016/j.bone.2010.05.019. Epub 2010 May 20. Review.

PMID:
20493982
5.

Do bisphosphonates cause femoral insufficiency fractures?

Seraphim A, Al-Hadithy N, Mordecai SC, Al-Nammari S.

J Orthop Traumatol. 2012 Dec;13(4):171-7. doi: 10.1007/s10195-012-0207-x. Epub 2012 Aug 1. Review.

6.

Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.

Iwamoto J, Takeda T, Sato Y.

Curr Med Res Opin. 2006 May;22(5):919-28. Review.

PMID:
16709313
7.

Atypical femoral fractures: what do we know about them?: AAOS Exhibit Selection.

Unnanuntana A, Saleh A, Mensah KA, Kleimeyer JP, Lane JM.

J Bone Joint Surg Am. 2013 Jan 16;95(2):e8 1-13. doi: 10.2106/JBJS.L.00568. Review. No abstract available.

PMID:
23324969
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk